这是用户在 2025-7-29 10:46 为 https://marquee.gs.com/content/girDisciplines/7fc73956-d6fd-11df-a204-00118563711b.html 保存的双语快照页面,由 沉浸式翻译 提供双语支持。了解如何保存?

Equity Research

TRADE POLICY IN FOCUS

The EU-US Trade Deal: A Smaller Increase in the Effective Tariff Rate Than in Our Baseline; Raising our Growth Projections

We estimate that the effective tariff rate on EU exports into the US increases from around 10% currently to about 16% with the deal, somewhat below our previous assumption. We thus revise down our estimate of the Euro area real GDP hit from trade-related tensions to -0.4% (from -0.6% previously). As a result of the deal and the better-than-expected activity dataflow, we raise our growth forecast for 2025 Q3 by 0.1pp, for 2025 Q4 by 0.2pp, and for Q1 2026 by 0.1pp, on a rounded basis. This raises our annual average growth forecast for 2025 and 2026 by 0.1pp each to 1.1% and 1.2%, respectively.

28 Jul 2025 | Research | Economics - Sven Jari Stehn and others

USA: US and EU Announce Trade Deal, Reducing Risks Ahead of Aug. 1 Deadline

The US and EU announced the outline of a trade agreement, setting the US tariff on most EU products at 15% (including autos, pharma and semis) and eliminating EU tariffs on US products. We have already assumed a general 15% tariff rate for the EU and other US trading partners in our baseline, but the 10pp reduction in the sectoral tariffs would reduce the ultimate US effective tariff rate by 0.7pp vs. our assumptions.

28 Jul 2025 | Research | Economics - Jan Hatzius and others

Also see:
GOAL Kickstart: Goldilocks extends with further declines in trade policy uncertainty (28 Jul 2025)
Copper: Minerals Diplomacy Implies Downside Risk To S232 Tariff Pricing (28 Jul 2025)
Japan: Revising up TOPIX Target to 3,200 after US-Japan trade deal; TPX hits an all-time-high (28 Jul 2025)
Global FX Trader: Deals Don't Derail Dollar Downside (25 Jul 2025)


View more on the Trade Policy page >

After consolidating for the better part of June and July, Chinese equities have recently broken out of their trading ranges, with MSCI China and CSI300 reaching their 4-year and ytd highs, respectively. Moderation of US-China trade tensions is perhaps a key contributor to the re-accelerating gains, in addition to a robust 2Q GDP print, government responses to address “involution” in key sectorsa resurgent IPO market in HK, record-breaking Southbound inflows (new 2025 GSe at US$160bn), and a wide gap between rising foreign investor interest in Chinese stocks and their still-conservative equity allocations. We retain our Overweight stance on China in a regional context, with our refreshed 12m index target pointing to 11% potential returns for MSCI China. But the 25% rally ytd (the 2nd best first seven-month returns since 2010) has further cemented our alpha over beta bias, leading us to reiterate Chinese POEs (Prominent 10) and shareholder yields thematically, and to raise Insurance and Materials (to OW) sectorally, funded by a downgrade in Banks and Real Estate.

28 Jul 2025 | 2:37am| 14pg| Research | Portfolio Strategy-Kinger Lau, CFA and others
Ahead of earnings for Baxter, GE Healthcare, Stryker, Siemens Healthineers, and Philips, we provide an in-depth analysis on the landscape for U.S. hospital CapEx spending, considering a multitude of evolving macro dynamics.
28 Jul 2025 | 7:30am| 19pg| Research | Equity-David Roman and others

IN THE SPOTLIGHT

https://publishing.gs.com/content/research/en/reports/2025/07/28/a63e717d-5cf1-432e-b9e8-b061254f3c96.html

While key debates have recently centered around the impact from volume based procurement (VBP) on overall healthcare (HC) spending, we highlight an increasingly important demographic — the 'silver' population (aged 50 and above) with strong 'Yuan' spending power (>Rmb3mn net worth). With this report, we introduce standalone TAM estimates for this '50+ >Rmb3mn NW' cohort, growing from Rmb221bn (US$31bn) to Rmb963bn (US$135bn) in 2024-35E, at a CAGR of 14.3%, vs. all-age/overall 50+ age population HC spending at 4.7%/5.3%, respectively. 

We highlight key stocks in our coverage best positioned to benefit from the rise in high-end out-of-pocket treatments: Aier (upgrade to Buy), Eyebright (Buy), Zhifei (upgrade to Buy), Topchoice (Neutral), and Straumann (Buy).

/content/research/authors/d2301b36-9b16-4472-9d02-3946266e3682.html

Tianyi Yan

China Healthcare | Shanghai
28 Jul 2025 | 4:23pm| 35pg| Research | Equity-Tianyi Yan and others
Also see:

This inaugural conference will bring together thought leaders and senior executives from the most important companies listed in Asia Pacific to present their corporate strategy, current trends and challenges. Running in parallel with the main presentations, companies will be hosting one-on-one and small group meetings.

RATING AND LIST CHANGES
Brazil Retail: Launch coverage on CEAB, VIVA at Buy; assume coverage on AZZA at Buy and SBFG at Neutral
29 Jul 2025 | 5:02am| 84pg| Research | Equity-Felipe Rached and others
China Healthcare: The Rise of the Silver Yuan
28 Jul 2025 | 4:23pm| 35pg| Research | Equity-Tianyi Yan and others
Topchoice Medical (600763.SS): Improving Visibility on LT Dental Implant Growth post VBP; up to Neutral
28 Jul 2025 | 4:13pm| 13pg| Research | Equity-Chris Pan, CFA and others
Latest research
European Chemicals: Dislocation opportunities; Buy pricing power & secular growth (NSIS, AIRP); Sell LXS post rerating
29 Jul 2025 | 10:32am| 12pg| Research | Equity-Georgina Fraser, Ph.D. and others
El Puerto De Liverpool (LIVEPOLC1.MX): Soft 2Q25 results
29 Jul 2025 | 10:16am| 8pg| Research | Equity-Irma Sgarz and others
Enterprise Products Partners LP (EPD): 2Q25 Recap: Midstream Margin Competition in Focus
29 Jul 2025 | 10:04am| 9pg| Research | Equity-John Mackay and others
Amkor Technology Inc. (AMKR): Solid near-term business momentum, but with gross margin headwinds
29 Jul 2025 | 9:54am| 7pg| Research | Equity-James Schneider, Ph.D. and others
Telefonica Brasil (VIV): First Take: In-Line, Re-Acceleration in Mobile Revenue
29 Jul 2025 | 9:33am| 9pg| Research | Equity-Vitor Tomita, CFA and others
Heineken (HEIN.AS): Cautious tone in H2 but fundamentals remain solid and valuation compelling
29 Jul 2025 | 9:14am| 16pg| Research | Equity-Olivier Nicolaï and others

Rating changes (last 24 hrs)

Drag here to set row groups
Drag here to set column labels
to of
Page of
* Contains active ratings and coverage designation. Source: Goldman Sachs Research

EPS changes (10% or more, last 24 hrs)

Drag here to set row groups
Drag here to set column labels
to of
Page of
* Contains active ratings and coverage designation. Source: Goldman Sachs Research

Price target changes (10% or more, last 24 hrs)

Drag here to set row groups
Drag here to set column labels
to of
Page of
* Contains active ratings and coverage designation. Source: Goldman Sachs Research
Recommended Publications
GS TWIG Notes
GS TWIG Notes has been added to your GS TWIG Notes
View new content in your feed and manage notifications
Get Email Alerts
Get Mobile Alerts
GS Equity Radar
GS Equity Radar has been added to your GS Equity Radar
View new content in your feed and manage notifications
Get Email Alerts
Get Mobile Alerts
Market Intelligence
Market Intelligence has been added to your Market Intelligence
View new content in your feed and manage notifications
Get Email Alerts
Get Mobile Alerts
US Morning Call
US Morning Call has been added to your US Morning Call
View new content in your feed and manage notifications
Get Email Alerts
Get Mobile Alerts
The 720
The 720 has been added to your The 720
View new content in your feed and manage notifications
Get Email Alerts
Get Mobile Alerts
Follow rating and list changes
Rating Initiate
You are now following Rating Initiate
View new content in your feed and manage notifications
Get Email Alerts
Get Mobile Alerts
Rating Upgrade
You are now following Rating Upgrade
View new content in your feed and manage notifications
Get Email Alerts
Get Mobile Alerts
Rating Downgrade
You are now following Rating Downgrade
View new content in your feed and manage notifications
Get Email Alerts
Get Mobile Alerts
DAILY ROUNDUPS
Midday Market Intelligence: checking in
29 Jul 2025 | 1:37am| 8pg| Research | Equity-Chris Hussey and others
Market Intelligence: US Morning Update
28 Jul 2025 | 8:03pm| 14pg| Research | Equity-Chris Hussey and others
WEEKLY ROUNDUPS
End of Week Market Intelligence: here, there...
26 Jul 2025 | 1:10am| 9pg| Research | Equity-Chris Hussey and others
GS TWIG Notes: This Week in Global Research - July 25, 2025
26 Jul 2025 | 1:09am| 12pg| Research | Equity-Chris Hussey and others
UPCOMING EVENTS & CONFERENCES
Global Investment Research in partnership with Global Banking & Markets
webcast: Asia
30 Jul 2025 | 10am HK | 10pm NY(-1) | 3am LN
This call is a part of China in Motion.
Yi Wang, CFA, Co-Head of Greater China Equity Research
Passcode: 560466; Meeting ID: 960 7894 7390
Global Investment Research
conference: Europe
30-31 Jul 2025 | Virtual | Goldman Sachs Office Plumtree Court, 25 Shoe Lane London EC4A 4AU
This year’s event will delve into key AI & Semis topics including scalability, enterprise adoption, agentic AI & robotics, challenges/bottlenecks,...Read more
Global Investment Research
webcast: Americas
31 Jul 2025 | 2pm NY | 7pm LN | 2am HK(+1)
Please reach out to your respective sales representative to participate.
Darren Richman, CEO, Millrose Properties Inc.
Garett Rosenblum, CFO, Millrose Properties Inc.
Robert Nitkin, COO, Millrose Properties Inc.
Jesse Ross, Head of Financial Planning and Analysis, Millrose Properties Inc.
Julien Blouin, Residential REITs Analyst
Global Investment Research
webcast: Americas
1 Aug 2025 | 10am NY | 3pm LN | 10pm HK
Please reach out to your respective sales representatives to participate.
Katie Fogertey, CFO, Shake Shack Inc.
Christine Cho, Americas Restaurants Equity Analyst

UPCOMING FEATURED CONFERENCES

European AI and Semis Symposium
30-31 Jul 2025 | London | Virtual
Register | Agenda

Asia Leaders Conference
3-5 Sep 2025 | Hong Kong with virtual access
Register

European Medtech & Healthcare Services Conference
3-4 Sep 2025 | London
Register | Agenda

32nd Annual Global Retailing Conference
3-4 Sep 2025 | New York
Register

Communacopia + Technology Conference
8-11 Sep 2025 | San Francisco
Register

European Communacopia Conference
16-17 Sep 2025 | London
Register

14th German Corporate Conference
22-24 Sep 2025 | Munich
Register

PAST CONFERENCES REPLAYS / TAKEAWAYS

Building an Investment Framework Conference
Replays > 

Global Copper Week
Replays & Takeaways > 

Global Pulp & Paper Week
Replays & Takeaways > 

European Financials Conference
Replays & Takeaways > 

Global Healthcare Conference
Replays & Takeaways > 

TechNet China
Replays & Takeaways > 

                                                                                                                                                                              View more >